Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06403943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is designed to further strengthen the clinical application evidence of BaidiZiyin Pill and ShenqiYifei Pill in the treatment of tuberculosis. To be included in the initial treatment of pulmonary tuberculosis patients, on the basis of standardized Western medicine treatment, BaidiZiyin Pills and ShenqiYifei Pills will be used to evaluate the clinical efficacy and safety of their products. 1. Evaluate the improvement of symptoms in the adjuvant treatment of newly treated pulmonary tuberculosis with BaidiZiyin Pill and ShenqiYifei Pill. 2. Explore the sputum negative conversion time and sputum negative conversion rate of BaidiZiyin Pill and ShenqiYifei Pill as adjunctive treatments for newly treated pulmonary tuberculosis. 3. Explore the protective effects of BaidiZiyin Pill and ShenqiYifei Pill on adverse reactions caused by chemotherapy.
Trial Details
NCT Number NCT06403943
Lead Sponsor Beijing Chest Hospital
Collaborators: The First Affiliated Hospital with Nanjing Medical University, Shenyang Tenth People's Hospital, Lanzhou Pulmonary Hospital, Hebei Chest Hospital, Anhui Chest Hospital, Chongqing Public Health, Chengdu Public Health Clinical Center, Guangzhou Chest Hospital., Third People's Court of Shenzhen, Heilongjiang Provincial Institute of Infectious Disease Prevention and Control, Wuhan tuberculosis Hospital, Suzhou Fifth Hospital
Conditions
(from sponsor)		 Adjuvant, Treatment, Tuberculosis
Related terms Tuberculosis
Enrollment 292 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov